(2)The non-inclusion of aldicarb in Annex I to Council Directive 91/414/EECnote is provided for in Council Decision 2003/199/ECnote and certain Member States were authorised to grant a period of grace expiring no later than 31 December 2007. The non-inclusion of bromopropylate, chlorfenvinphos, EPTC, ethion, fomesafen, tetradifon and triforine is provided for in Commission Regulation (EC) No 2076/2002note and certain Member States were authorised to grant a period of grace expiring no later than 31 December 2007. The non-inclusion of endosulfan in Annex I to Directive 91/414/EEC is provided for in Commission Decision 2005/864/ECnote and certain Member States were authorised to grant a period of grace expiring no later than 31 December 2007. The non-inclusion of fenthion in Annex I to Directive 91/414/EEC is provided for in Commission Decision 2004/140/ECnote and certain Member States were authorised to grant a period of grace expiring no later than 31 December 2007. The non-inclusion of methabenzthiazuron in Annex I to Directive 91/414/EEC is provided for in Commission Decision 2006/302/ECnote and certain Member States were authorised to grant a period of grace expiring no later than 31 December 2009. The non-inclusion of methidathion in Annex I to Directive 91/414/EEC is provided for in Commission Decision 2004/129/ECnote and certain Member States were authorised to grant a period of grace expiring no later than 31 December 2007.The non-inclusion of simazine in Annex I to Directive 91/414/EEC is provided for in Commission Decision 2004/247/ECnote and certain Member States were authorised to grant a period of grace expiring no later than 31 December 2007.